Coldwell Foundation donates $100,000 for the Study of Anti-Pancreatic Cancer Agent

Ramadevi Subramani Reddy, Ph.D.

Ramadevi Subramani Reddy, Ph.D.

The Lizanell and Colbert Coldwell Foundation has donated $100,000 to help Ramadevi Subramani Reddy, Ph.D., study a potential treatment for pancreatic cancer.

Subramani Reddy, a researcher at the Center of Emphasis in Cancer Research at Texas Tech University Health Sciences Center El Paso, is studying the anti-cancer effects of gedunin, a natural compound from the Azadirachta indica tree native to the Indian subcontinent. Early research suggests gedunin could serve as an anti-cancer agent against pancreatic cancers.

Though pancreatic cancer survival rates have been improving, the disease is still largely considered incurable. The five-year survival rate for pancreatic cancer is 9 percent, according to the American Cancer Society. Nearly 46,000 people will die nationwide of pancreatic cancer in 2019.

The Lizanell and Colbert Coldwell Foundation gives to Texas organizations to further the advancement of medical sciences, and research institutions dedicated to medical research, especially for the cure and prevention of heart disease and cancer.